| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |